Page last updated: 2024-09-03

heptakis(2,6-o-dimethyl)beta-cyclodextrin and Breast Cancer

heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ağardan, NB; Altıntaş, L; Değim, Z; Topal, T; Yılmaz, Ş1

Other Studies

1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and Breast Cancer

ArticleYear
The Effectiveness of Raloxifene-Loaded Liposomes and Cochleates in Breast Cancer Therapy.
    AAPS PharmSciTech, 2016, Volume: 17, Issue:4

    Topics: Animals; Antineoplastic Agents; beta-Cyclodextrins; Breast Neoplasms; Caco-2 Cells; Cell Line, Tumor; Chemistry, Pharmaceutical; Female; Humans; Liposomes; Matrix Metalloproteinase 2; MCF-7 Cells; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Taurocholic Acid

2016